Table 1.
Age, BMI, blood lipid level and antioxidant status in lower lipid, higher lipid and hyperlipidemic groups
Variable | normolipidemic subjects (n = 30) | hyperlipidemic subjects (n = 15) | |
---|---|---|---|
Group I (lower) | Group II (higher) | Group III | |
n | 15 | 15 | 15 |
Sex (male/female) | 9/6 | 9/6 | 10/5 |
Age, years | 49.75 ± 10.15 | 51.35 ± 11.20 | 52.23 ± 11.80 |
BMI, kg/m2 | 21.82 ± 2.71 | 22.95 ± 2.45 | 24.95 ± 3.12 |
Total cholesterol (mmol/L) | 4.04 ± 0.69a | 4.83 ± 0.87b | 5.05 ± 0.91b |
Triglycerides (mmol/L) | 0.48 ± 0.14a | 1.24 ± 0.04b | 3.20 ± 1.19c |
HDL-C (mmol/L) | 1.45 ± 0.16a | 1.21 ± 0.12b | 1.05 ± 0.10c |
LDL-C (mmol/L) | 1.90 ± 0.57a | 3.09 ± 0.89b | 2.82 ± 0.94b |
TAC (U/ml) | 11.54 ± 1.56a | 12.63 ± 1.29a | 12.29 ± 1.67a |
SOD (U/ml) | 110.18 ± 18.82a | 92.05 ± 20.35b | 90.15 ± 22.35b |
GSH-PX (U/ml) | 220.92 ± 37.80a | 185 ± 30.7b | 172.54 ± 32.23c |
MDA (nmol/ml) | 10.53 ± 2.50a | 13.89 ± 3.80a | 26.12 ± 5.93b |
Values are expressed as mean ± SD for 15 subjects. Values in the same line with different superscripts are significantly different at p<0.05 level, as assessed by a one-way analysis of variance. BMI indicates body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein.